<< Back to the abstract archive
Incidence of psychiatric medication in the migraine surgery population
Cameron Erickson BS, Michelle Lee MD, Bahman Guyuron MD
University Hospitals Case Medical Center, Case Western Reserve University
2015-02-25
Presenter: Cameron Erickson
Affidavit:
I certify that the material proposed for presentation in this abstract has not been published in any scientific journal or previously presented at a major meeting. This work represents the original work of the authors.
Director Name: Hooman Soltanian
Author Category: Medical Student
Presentation Category: Clinical
Abstract Category: Aesthetics
Background: A recent report in 2011 estimates that 1 in 5 Americans are on a psychiatric medication.1 Antidepressant and anxiolytic medications make up the majority of prescription psychiatric medications in use today. The aim of this study is to discover the incidence of psychiatric medication use in the migraine surgery population.
Methods: A retrospective chart review of 100 patients undergoing migraine surgery performed by a single surgeon was reviewed. Patient's charts were reviewed for demographics, surgical procedure, and psychiatric medication use. Exclusion criteria included migraine surgery in the past and deficient preoperative medication form. Patients were subdivided into a psychiatric medication user group and a non-psychiatric medication user group. Statistical analysis included descriptive statistics, t-test, and chi-square analysis.
Results: The incidence of psychiatric medication use was 59 percent in the 100 patients; 52 percent of the patients used an antidepressant, 20 percent used an anxiolytic, 1 percent used a mood stabilizer, and 5 percent used a neuroleptic medication. In the psychiatric medication group, patients used an average of 1.5 psychiatric medications daily. The antidepressant group and non-antidepressant groups differed significantly in age (antidepressant, 45.7 years; non-antidepressant, 40.7 years; p < 0.04).
Conclusions: Psychiatric medication use is prevalent in the migraine surgery population, even more so in the older population. Considering the potential difficulties that may arise when distinguishing between psychiatric medication being used for prophylactic migraine treatment versus those suffering from depression or anxiety, these results underline the importance of a thorough psychiatric history in this unique patient population.
